NKTR
Nektar Therapeutics
Halal Rating :
Last Price
$0.90
Last updated:
Market Cap
-
7D Change
-6.21%
1 Year Change
76.75%
Company Overview
Industries
Exchange
Next Earnings Date
Nektar Therapeutics is a biopharmaceutical company focused on developing novel medicines in areas of oncology and immunology. The company discovers and develops innovative medicines using its proprietary chemistry and drug development platforms. Their business model is primarily focused on research and development of new therapeutic compounds.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $24.12m | $64.49m | - | $6.02m | 0.00% | 9.33% |
| June 30, 2024 | $23.49m | $79.67m | - | $6.41m | 0.00% | 8.04% |
| March 31, 2024 | $21.64m | $62.6m | - | $5.53m | 0.00% | 8.84% |
Company Impact
Help us evaluate Nektar Therapeutics's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.